Arterionephrosclerosis (Hypertensive Nephrosclerosis): A Patient Guide
At a Glance
Arterionephrosclerosis is kidney damage from long-standing high blood pressure that scars the kidneys’ small blood vessels and filters. Existing scars cannot be reversed, but careful blood pressure and cardiovascular risk control can slow further loss of kidney function.
Arterionephrosclerosis, historically referred to as hypertensive nephrosclerosis, is a condition where the kidneys sustain chronic damage due to long-standing high blood pressure. Over time, the force of blood pushing against the walls of the kidney’s smallest blood vessels causes them to thicken and narrow. This narrowing starves the kidney’s delicate filtering units, known as glomeruli, of the oxygen and nutrients they need to function. As these filters are deprived of blood flow, they can turn into scar tissue, a process that gradually reduces the kidney’s ability to clear waste from the body [1][2].
In most people, this condition follows a chronic (historically called “benign”) course, progressing silently over many years without causing obvious physical symptoms. However, the term “benign” is misleading, as the condition still requires serious attention. Furthermore, if blood pressure rises to extremely high levels very quickly, the damage can become “malignant” or accelerated, causing an acute injury that requires immediate emergency medical intervention. Because the early stages of the disease are often silent, diagnosis usually relies on a probabilistic approach, where doctors look at a patient’s history of high blood pressure and declining kidney function while carefully ruling out other “mimicking” diseases, such as immune-related inflammation or diabetes, that can look similar on standard tests [3][4].
While existing scar tissue in the kidneys cannot be reversed, treatment can significantly slow further loss and preserve function for many years. Management focuses on shielding the remaining healthy kidney filters from further stress. This is primarily achieved through strict, individualized blood pressure control, often using specific classes of medication. Because high blood pressure is a “whole-body” condition, protecting the kidneys also requires a dedicated focus on cardiovascular health—including cholesterol management, smoking cessation, diabetes control, and physical activity. By managing these factors effectively, you are not only preserving your kidney function but also significantly reducing the risk of complications in the heart and brain, allowing for a proactive and manageable path forward [5][6].
In this guide
5 chapters
Understanding High Blood Pressure and Your Kidneys
Learn how arterionephrosclerosis affects kidney function, how doctors diagnose it, and how blood pressure control, urine tests, and medicines protect your kidneys.
Monitoring Symptoms and Red Flags
Learn why arterionephrosclerosis can stay silent, spot advanced kidney symptoms, and know when a blood pressure reading requires immediate emergency care.
Inside the Kidney: Scarring and Structural Changes
Learn how arterionephrosclerosis causes kidney scarring, what IFTA and glomerulosclerosis mean, and which biopsy or urine findings may suggest another diagnosis.
Treatment Options and Protecting Your Kidneys
Learn how arterionephrosclerosis treatment protects kidney function with blood pressure targets, ACE inhibitors, SGLT2 drugs, sodium limits, and monitoring.
Long-Term Outlook and Staying on Track
Learn how arterionephrosclerosis affects long-term kidney and heart health, how eGFR and UACR trends guide risk, and what medication monitoring involves.
Common questions in this guide
What is arterionephrosclerosis, also called hypertensive nephrosclerosis?
How do doctors determine whether high blood pressure caused my kidney damage?
What symptoms should I watch for with hypertensive nephrosclerosis?
Can kidney scarring from arterionephrosclerosis be reversed?
What can I do to protect my kidneys and heart?
Does hypertensive nephrosclerosis increase the risk of heart disease or stroke?
What happens if blood pressure rises suddenly to an extremely high level?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Based on my medical history, how certain are we that high blood pressure is the primary cause of my kidney damage?
- 2.Are there any signs in my blood or urine tests that suggest we should look for 'mimicking' conditions like glomerulonephritis?
- 3.How does the scarring in my kidneys affect my overall risk for heart disease or stroke?
- 4.What are the most important lifestyle changes I can make right now to support my blood pressure medications?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (6)
- 1
Hypertensive Nephrosclerosis: Pathological Changes and Overlap with Diabetic Nephropathy.
Qasim H, Ktaifan M, Awawdeh A, et al.
Cureus 2025; (17(9)):e92949 doi:10.7759/cureus.92949.
PMID: 41141162 - 2
Molecular Mechanisms of Hypertensive Nephropathy: Renoprotective Effect of Losartan through Hsp70.
Costantino VV, Gil Lorenzo AF, Bocanegra V, Vallés PG
Cells 2021; (10(11)) doi:10.3390/cells10113146.
PMID: 34831368 - 3
Clinical Phenotypes and Long-term Prognosis in White Patients With Biopsy-Verified Hypertensive Nephrosclerosis.
Øvrehus MA, Oldereid TS, Dadfar A, et al.
Kidney international reports 2020; (5(3)):339-347 doi:10.1016/j.ekir.2019.12.010.
PMID: 32154455 - 4
Novel Haplotype Indicator for End-Stage Renal Disease Progression among Saudi Patients.
Cyrus C, Chathoth S, Vatte C, et al.
International journal of nephrology 2019; (2019()):1095215 doi:10.1155/2019/1095215.
PMID: 31534799 - 5
[Classical nephroprotection: Renin angiotensin aldosterone system inhibitors].
Egocheaga MI, Drak Y, Otero V
Semergen 2023; (49 Suppl 1()):102018 doi:10.1016/j.semerg.2023.102018.
PMID: 37355297 - 6
Patients with biopsy-proven nephrosclerosis and moderately impaired renal function have a higher risk for cardiovascular disease: 15 years' experience in a single, kidney disease center.
Suzuki H, Kobayashi K, Ishida Y, et al.
Therapeutic advances in cardiovascular disease 2015; (9(3)):77-86 doi:10.1177/1753944715578596.
PMID: 25838316
This page is for informational purposes only and does not constitute medical advice about arterionephrosclerosis. Your clinician should interpret your kidney tests and tailor blood pressure treatment to your specific situation.
Get notified when new evidence is published on arterionephrosclerosis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.